Harmony Biosciences Holdings, Inc. HRMY Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $145.62M-4.7% | $158.69M+9.1% | $185.68M+51.4% | $180.9M+57.3% | $152.72M+10.9% | ||
| —— | —— | $26K-93.9% | $26K-95.4% | $111K-80.7% | ||
| $43.02M-3.8% | $44.9M+5.4% | $45M+8.7% | $45.07M+17.6% | $44.71M+28.1% | ||
| $341.97M+53.6% | $348.2M+58.4% | $297.61M+34.7% | $259.38M+21.5% | $222.67M+7.1% | ||
| —— | $310K-73.1% | $716K-4.1% | $648K— | $1.28M— | ||
| -$225.66M-278% | -$39.65M+41.9% | -$29.2M+69.9% | -$24.41M+75.1% | -$59.68M-17.4% | ||
| $17.5M+16.7% | $16.25M+8.3% | $15M0.0% | $15M+33.3% | $15M+87.5% | ||
| -$15.92M-106% | -$9.05M+17.7% | -$8.78M+85.8% | -$6.95M+94.0% | -$7.71M+93.1% | ||
| $100.4M— | $299.5M— | $259.63M— | $228.75M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Harmony Biosciences Holdings, Inc.'s cash flow data come from?
- Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.